Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital Setting

Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital Setting

Adalimumab is used at 40-mg dose to treat systemic inflammatory diseases. Given the impact of adverse drug reactions (ADRs), which particularly result in the discontinuation of adalimumab therapy in female patients, this study examined whether sex affects the frequency and type of ADRs induced by ad...

Full description

Bibliographic Details
Main Authors: Kwi Suk Kim, Young Hee Choi, Aree Moon, Sang Geon Kim
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Journal of Clinical Medicine
Subjects:
adalimumab
adverse drug reaction
gender
body weight
skin
infection
test abnormality
Online Access:https://www.mdpi.com/2077-0383/9/2/461

Similar Items

Similar Items